New Year Speech by Party Secretary and Chairman of the Board of Directors of the Group Company
Release time:
2023-01-29
, secretary of the party Committee and chairman of
group company, is not living in the past five years, and the season is like a stream.
bid farewell to the challenging and extraordinary 2022 . We are stepping into the changing situation with hope and 2023 with strength in striving.
Here, on behalf of the group company, I would like to express my sincere greetings to all the cadres and employees who have worked hard and dedicated for the past year. I would like to say to my colleagues who still stick to their posts during the festival and even stay far away from home: hard work.
2022 , the complex and volatile new crown epidemic, rising basic raw materials and shrinking demand and other adverse factors, to the Group's development has brought great pressure and severe challenges. However, we still overcome difficulties, seize development opportunities, move forward vigorously, strictly implement the requirements of General Secretary "epidemic situation should be prevented, economy should be stable, development should be safe " , strengthen confidence, calmly respond, seek opportunities in crisis, seek progress in stability, spare no effort to stabilize growth, prevent risks, promote reform, grasp management and strengthen party building, laying a foundation for the sustained and healthy development of the group, A tribute to the party's 20th congress.
This year, with the joint efforts of all peak employees, we have successively won "China's Top 100 Cement Clinker Production Enterprises " , "2021 Taurus Most Investment Value Award " , China's Cement Brand Influence "Intelligent Factory Leading Enterprise " , Zhejiang "Provincial Water Saving Benchmarking Enterprise " , Yunnan "A series of honors such as harmonious labor relations enterprise " , Guizhou "provincial green factory " , corporate image and influence have increased significantly.
This year, we always take responsibility. In the face of the raging epidemic, while doing a good job in the prevention and control of the internal epidemic, we also donated money and materials to the government, anti-epidemic personnel and charitable organizations where the enterprise is located, and actively cooperated with government departments to reserve epidemic prevention materials and ensure market supply by taking advantage of channels, thus making positive contributions to the joint force "war epidemic " ; We actively put into the cause of rural revitalization, every year, we visit the poor people in the economically weak villages where the enterprises are located, and carry out joint construction and common prosperity actions in pairs, so as to help strengthen the village and enrich the people and help realize common prosperity.
All the achievements of this year are the result of the hard work and sweat of the company's employees, and are the result of all the peak people expressing their responsibilities and creating achievements through hard work. The new year brings new hope and new challenges. 2023 is a key year for the country "14 15 " , and it is also the 67th anniversary of Jianfeng Group's listing 30#. We should focus on long-term development, keep close to the pulse of the times, grasp market opportunities, and use innovation to create a new engine for the Group's high-quality development.
Strive for a new era and live up to your youth to embark on a new journey! Let's treasure our glory, step on the drumbeat of the times with confidence, define time with struggle, water harvest with sweat, actively explore the high-quality development path of Jianfeng Group, forge ahead towards the goal of "to create a century-old peak " , and create brilliant new achievements on the new journey of realizing the beautiful vision of Jianfeng people with wisdom and sweat.
Finally, I wish everyone a happy New Year, a happy family, good health and all the best!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page